New drug shows promise for Hard-to-Treat throat cancer

NCT ID NCT05126719

Ongoing Disease control Sponsor: Shanghai Miracogen Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a drug called MRG003 in adults whose nasopharyngeal cancer has come back or spread and hasn't responded to standard treatments. The goal is to see if the drug can shrink tumors and how safe it is. About 238 participants will receive the drug, and researchers will track tumor response and side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECURRENT OR METASTATIC NASOPHARYNGEAL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

nasopharyngeal carcinoma Recurrence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RECURRENT OR METASTATIC NASOPHARYNGEAL CARCINOMA

Contacts and locations

Show contact details

Locations

Cancer Hospital of Shantou University Medical College

Shantou, Guangdong, 515041, China
Chongqing University Cancer Hospital

Chongqing, Chongqing Municipality, 400030, China
First Affiliated Hospital of Gannan Medical University

Ganzhou, Jiangxi, 341001, China
Fujian Cancer Hospital

Fuzhou, Fujian, 350014, China
Ganzhou Cancer Hospital

Ganzhou, Jiangxi, 341005, China
Guangxi Medical University Affiliated Tumor Hospital

Nanning, Guangxi, 530021, China
Guigang City People's Hospital

Guigang, Guangxi, 537199, China
Hainan General Hospital

Haikou, Hainan, 570311, China
Henan Cancer Hospital

Zhengzhou, Henan, 450003, China
Hunan Cancer Hospital

Changsha, Hunan, 410031, China
Jiangxi Cancer Hospital

Nanchang, Jiangxi, 330029, China
Maoming People's Hospital

Maoming, Guangdong, 525000, China
Peking University Cancer Hospital

Beijing, Beijing Municipality, 100142, China
People's Hospital of Guangxi Zhuang Autonomous Region

Nanning, Guangxi, 530021, China
Shanghai East Hospital

Shanghai, Shanghai Municipality, 200123, China
Sichuan Cancer Hospital

Chengdu, Sichuan, 610041, China
Sun Yat-sen University Cancer Center

Guangzhou, Guangdong, 510000, China
The Affiliated Cancer Hospital of Guizhou Medical University

Guiyang, Guizhou, 550000, China
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, Hubei, 430022, China
Yibin Second People's Hospital

Yibin, Sichuan, 644000, China
Yue Bei People's Hospital

Shaoguan, Guangdong, 512026, China
Zhejiang Cancer Hospital

Hangzhou, Zhejiang, 310022, China
Zhongshan City People's Hospital

Zhongshan, Guangdong, 528403, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.